Innovations and advances in the sector will drive growth

[ad_1]

Company logo

enteral-feeding-formulas-market-share.jpg

Dublin, Oct. 31, 2022 (GLOBE NEWSWIRE) — “Global Enteral Nutrition Formulas Market Size, Share and Industry Trends Analysis Report By End User, By Application (Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes), By Period Product, regional forecast and forecast 2022 – 2028” report added ResearchAndMarkets.com offer.

The global enteral feeding formulas market size is expected to reach USD 8.6 billion by 2028, growing at a market CAGR of 8.5% during the forecast period.

Nutrition is considered in conditions such as cancer, eating difficulties, serious illness, stroke and life-threatening injuries. Eating solid food or a regular diet can be replaced by tube feeding and nutrition. Enteral feeding, especially for people with chronic diseases, is usually carried out by a doctor’s prescription and with the help of medical personnel.

When oral intake has little effect on growth and nutritional status, enteral feeding can be initiated. Enteral feeding can be administered through nasogastric tubes, gastrostomy tubes, and jejunostomy tubes. Based on the knowledge of the care center, the method of selection and placement of enterostomy tubes is developed. In highly motivated patients, nasogastric tubes are suitable for providing short-term nutrition. Gastrostomy tubes are a good option for people who need enteral nutrition for a long time.

Increasing demand for enteral feeding formulas for seniors at home is also leading to an increase in the number of manufacturers contributing to the expansion of the enteral feeding formula market. This market is also expanding as many nursing homes and home health organizations prefer enteral feeding formulas to rehabilitate post-surgical patients. As the neonatal care units develop, the market for enteral feeding formulas will continue to grow.

Market growth factors

Enteral feeding is easier and less expensive to administer

Artificial nutrients or drugs are introduced into the gastrointestinal tract through oral feeding. Parenteral nutrition uses a catheter to administer intravenous nutrition or medication into the bloodstream through central or peripheral veins. Parenteral nutrition is more difficult than enteral nutrition. In critically ill patients requiring nutritional support therapy, enteral nutrition has been highlighted in the American Society for Parenteral and Enteral Nutrition (ASPEN) guidelines as a nutritional option superior to parenteral nutrition.

Increasing advances and innovation in enteral feeding products

The number and variety of enteral formulas used worldwide has increased significantly over the past few years. Today, there are more than 1,000 enteral formulations, and businesses are introducing new products to attract a wider range of customers. To meet demand for nutritional supplement formulas for tube-fed patients, one such example is Abbott, which in 2019 introduced PediaSure Harvest and Ensure Harvest, a new blend of real food ingredients from sources such as mango, spinach. , carrot, pumpkin and banana. The choice of enteral nutrition formula should take into account the patient’s nutritional needs, physical condition, GI function, general health, including medical history and metabolic abnormalities, and desired outcomes.

Factors inhibiting the market
Lack of knowledge about prescribing enteral feeding in disorders

Despite the existence of many validated clinical practice guidelines for enteral nutrition in critically ill patients, there is still a significant discrepancy between clinical practice guideline recommendations and actual nutritional outcomes. Malnutrition is another common problem. Hospital units should now increase standardization and training in systemic enteral nutrition, provide full-time nutritionists for ICUs, and logically allocate medical resources and staff to provide minimal constraints to market expansion. This misunderstanding of the proper use of enteral feeding is expected to adversely affect the growth of the enteral feeding formulas market.

Scope of research
Market segments covered in the report:

By end user

Hospitals
Long-term care products
Nursing homes
Assisted living facilities
Home care agencies and hospices

By application

According to the scene

By product

By geography

Major market players

Abbott Laboratories
Danone SA (Sofina Group)
Nestle SA
Fresenius SE & Co. KGaA
B. Braun Melsungen AG
Otsuka Pharmaceutical Co., Ltd.
Meiji Holdings Co., Ltd.
Reckitt Benckiser Group PLC
Hormel Foods Corporation
Medline Industries, Inc.

Key topics covered:

Chapter 1. Market scope and methodology

Chapter 2. Market overview

Chapter 3. Strategies used in enteral feeding market

Chapter 4. Global End User Enteral Nutrition Formulas Market

Chapter 5. Global Enteral Nutrition Formulas Market by Application

Chapter 6. Global Enteral Nutrition Formulas Market by Period

Chapter 7. Global enteral feeding formulas market by product

Chapter 8. Global Enteral Nutrition Formulas Market by Region

Chapter 9. Company profiles

For more information on this report, visit https://www.researchandmarkets.com/r/fw4vfe.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900